Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
595 JPY | -1,82% |
|
+2,06% | -49,23% |
31/05 | JCR Pharmaceuticals' winst over het hele jaar met 46% gestegen | MT |
27/05 | JCR PHARMACEUTICALS CO., LTD. : Jefferies & Co. is Neutraal over het aandeel | ZM |
Vakgebied
Aantal werknemers: 879
Verkoop per activiteit
JPY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 51 082 | 100,0 % | 34 343 | 100,0 % | -32,77% |
Verkoop per regio
JPY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Japan
100,0
%
| 51 082 | 100,0 % | 34 343 | 100,0 % | -32,77% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Shin Ashida
CEO | Chief Executive Officer | 81 | 13-09-75 |
Hiroyuki Sonoda
CTO | Chief Tech/Sci/R&D Officer | 46 | 01-04-03 |
Yutaka Honda
ADM | Chief Administrative Officer | - | - |
Yoshio Hiyama
BRD | Director/Board Member | - | 01-04-19 |
Mathias Schmidt
BRD | Director/Board Member | 56 | 01-06-20 |
Takashi Suetsuna
BRD | Director/Board Member | 75 | 01-06-16 |
Toru Ashida
BRD | Director/Board Member | 55 | 01-01-14 |
Masaki Sumiyoshi
HRO | Human Resources Officer | - | - |
Masaya Ichikawa
AUD | Comptroller/Controller/Auditor | - | - |
Sales & Marketing | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Shin Ashida
CEO | Chief Executive Officer | 81 | 13-09-75 |
Toshihide Yoda
BRD | Director/Board Member | 61 | 27-06-18 |
Philippe Fauchet
BRD | Director/Board Member | 65 | - |
Toru Ashida
BRD | Director/Board Member | 55 | 01-01-14 |
Director/Board Member | 71 | 01-06-15 | |
Takashi Suetsuna
BRD | Director/Board Member | 75 | 01-06-16 |
Yutaka Atomi
BRD | Director/Board Member | 79 | - |
Yuko Hayashi
BRD | Director/Board Member | 59 | 27-06-18 |
Hiroyuki Sonoda
CTO | Chief Tech/Sci/R&D Officer | 46 | 01-04-03 |
Yoshio Hiyama
BRD | Director/Board Member | - | 01-04-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 129 686 308 | 68 696 394 ( 52,97 %) | 4 881 914 ( 3,764 %) | 52,97 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
4 585 900 | 3.54% | 16 750 825 $ | |
204 000 | 0.54% | 3 933 438 $ |
Bedrijfsgegevens
JCR Pharmaceuticals Co., Ltd.
3-19 Kasuga-cho
659-0021, Ashiya
+81 7 9732 8591
http://www.jcrpharm.co.jp![Adres JCR Pharmaceuticals Co., Ltd.(4552)](https://cdn.zonebourse.com/static/address/11551531.png)
Sector
![Consensus](/images/consensus_flch.gif)
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-49,23% | 461 mln. | |
+55,19% | 801 mld. | |
+47,26% | 631 mld. | |
-6,09% | 359 mld. | |
+21,92% | 337 mld. | |
+18,40% | 245 mld. | |
+3,64% | 231 mld. | |
+12,98% | 219 mld. | |
+10,86% | 171 mld. | |
-2,78% | 161 mld. |
- Beurs
- Aandelen
- Koers 4552
- Onderneming JCR Pharmaceuticals Co., Ltd.